Lung Cancer | Specialty

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Dr. Choi on Using Low-Dose CT Scans to Screen for Lung Cancer

October 26th 2019

Humberto Choi, MD, discusses using low-dose CT scans to screen patients with a high-risk of developing lung cancer.

Surgeon Sheds Light on Early-Stage Interventions in Lung Cancer

October 25th 2019

Daniela Molena, MD, discusses the role of screening and the implementation of minimally invasive surgical techniques in early-stage lung cancer.

Dr. Kim on Clinical Trial Eligibility Criteria in Lung Cancer

October 25th 2019

Edward S. Kim, MD, discusses clinical trial eligibility criteria in lung cancer.

Tissue Versus Liquid Biopsies in BRAF+ NSCLC

October 24th 2019

Emerging Therapies and Unmet Needs in BRAF+ NSCLC

October 24th 2019

Advances in BRAF+ NSCLC: Targeted Therapy

October 24th 2019

METex14-Mutated NSCLC: Next Steps in Research

October 24th 2019

Adopting Newer MET Inhibitors Into Practice in NSCLC

October 24th 2019

Targeted Therapy for METex14-Mutated NSCLC

October 24th 2019

Treating METex14 Mutations in NSCLC

October 24th 2019

Tissue Conservation and Liquid Biopsies in NSCLC

October 24th 2019

Evolution of Molecular Testing in NSCLC

October 24th 2019

Identifying Rare Mutations in NSCLC

October 24th 2019

MET as a Driver in NSCLC

October 24th 2019

Next Steps in Research for BRAF-Mutant NSCLC

October 24th 2019

Role of ctDNA in NSCLC

October 24th 2019

Molecular Testing Approaches in NSCLC

October 24th 2019

Emerging Therapies for BRAF-Mutated NSCLC

October 24th 2019

Safety Profiles of BRAF/MEK Inhibitors

October 24th 2019

Treatment Options for BRAF-Mutated NSCLC

October 24th 2019